In Vivo Biologics Design

Transforming protein therapeutics discovery with high-throughput
in vivo measurement

Manifold Bio is a therapeutics company with an unprecedented advantage in engineering precision biologics. We have developed the world’s first high-throughput in vivo drug design platform, enabled by a novel protein barcoding technology and other innovations at the interface of molecular biology and compute.

mDesign™ Platform

With our mCodes™ technology, we've unlocked protein multiplexing for pooled in vivo testing of complex biologics.

Our Platform

Advancing Therapeutic Possibilities

Discover how our innovative platform unlocks the next generation of complex biologics across a range of therapeutic areas.

Learn More

Stay up to date

See All
Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform
Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform
Read Article
In Vivo Biologics Design for Next-Generation Targeting
In Vivo Biologics Design for Next-Generation Targeting
Read Blog
Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck
Manifold Bio’s molecular ‘barcodes’ could break through pharma’s in vivo bottleneck
Read Article

Careers

Join us on our mission to transform protein therapeutics discovery.
View Open Positions

Excited about the vision? Contact us today!

Contact Us